Prognosis After Resection of Residual Masses in Testicular Cancer
Author Information
Author(s): E.W. Steyerberg, H.J. Keizer, J. Zwartendijk, G.L. Van Rijk, C.J. Van Groeningen, J.D.F. Habbema, G. Stoter
Primary Institution: University Hospital Leiden
Hypothesis
What are the prognostic factors affecting relapse and survival after resection of residual masses following chemotherapy for metastatic nonseminomatous testicular cancer?
Conclusion
The study found that the completeness of resection and prechemotherapy HCG levels are significant predictors of relapse in patients with testicular cancer.
Supporting Evidence
- Eleven patients relapsed during follow-up, accounting for a 5-year relapse-free percentage of 87.4%.
- Adverse prognostic factors included prechemotherapy HCG levels greater than 10,000 IU and incomplete resection.
- The histology found at resection was not associated with the risk of relapse.
- Most relapses occurred within 12 months after surgery.
Takeaway
Doctors looked at 86 patients with testicular cancer who had surgery after chemotherapy. They found that how well the surgery went and certain blood test results can help predict if the cancer will come back.
Methodology
The study analyzed patient data from 210 patients, focusing on 86 who had normal tumor markers and underwent surgery for residual masses, using statistical methods like Kaplan-Meier curves and Cox regression.
Limitations
The study may have limitations due to the relatively small sample size and the exclusion of patients treated outside standard protocols.
Participant Demographics
Median age of patients was 26.5 years, with a majority having teratocarcinoma or embryonal carcinoma.
Statistical Information
P-Value
0.0004
Confidence Interval
95% CI: 78%-93%
Statistical Significance
p<0.05
Want to read the original?
Access the complete publication on the publisher's website